Guardant Health files Form 144 to resell 4,000 shares

Guardant Health filed a Form 144 reporting proposed resale of 4,000 shares of Common Stock via a cashless employee option exercise on 07/01/2026.

Rhea-AI Filing Summary

Guardant Health filed a Form 144 reporting proposed resale of 4,000 shares of Common Stock via a cashless employee option exercise on 07/01/2026. The filing also lists recent open-market sales by Meghan V. Joyce totaling 20,203 shares across June 2026 with proceeds shown per trade.

Insights

Equity Capital Markets Analyst

Routine resale notice tied to an employee option exercise and recent insider sales.

The filing lists a proposed sale of 4,000 shares by means of an employee stock option exercise with broker payment for cashless exercise on 07/01/2026. Form 144s notify regulators of intended resale rather than guarantee a transaction will occur.

Recent transactions by Meghan V. Joyce show multiple open-market sales in June 2026 with per-trade proceeds noted; cash-flow treatment is reported per sale. These items are administrative disclosures and do not by themselves imply material company-level effects.

Key Figures

Proposed resale: 4,000 shares Sale on 06/03/2026: 10,000 shares Sale on 06/22/2026: 6,203 shares +2 more

5 metrics

Proposed resale 4,000 shares Employee Stock Option Exercise dated 07/01/2026

Sale on 06/03/2026 10,000 shares Proceeds $1,269,809.00

Sale on 06/22/2026 6,203 shares Proceeds $812,604.00

Sale on 06/24/2026 2,000 shares Proceeds $280,045.00

Sale on 06/26/2026 2,000 shares Proceeds $300,082.00

Key Terms

cashless exercise, Form 144, Employee Stock Option Exercise

3 terms

cashless exercise financial

"Broker Payment for Cashless Exercise"

A cashless exercise is a way for an option holder to convert stock options into actual shares without paying the purchase price in cash; instead they immediately give up a portion of the newly issued shares to cover the cost and any withholding taxes. Investors care because this process increases the number of shares available and can slightly dilute existing holdings, while also signaling how insiders or employees are realizing compensation without needing cash — similar to paying for a purchase by handing over part of what you just bought.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Employee Stock Option Exercise financial

"Employee Stock Option Exercise | 07/01/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Guardant Health's Form 144 (GH) disclose?

The Form 144 discloses a proposed resale of 4,000 common shares via an employee stock option cashless exercise dated 07/01/2026. It also lists multiple June 2026 open-market sales by Meghan V. Joyce with proceeds per trade included.

Who is listed as selling shares in the Guardant Health filing?

The filing lists an employee option-based proposed resale of 4,000 shares and recent open-market sales by Meghan V. Joyce on 06/03/2026, 06/22/2026, 06/24/2026, and 06/26/2026 with proceeds listed for each trade.

What were the proceeds reported for Meghan V. Joyce's June 2026 sales?

The reported proceeds are $1,269,809.00 on 06/03/2026, $812,604.00 on 06/22/2026, $280,045.00 on 06/24/2026, and $300,082.00 on 06/26/2026, as shown in the Form 144 excerpt.

Does the Form 144 mean the 4,000 shares were sold?

No. The Form 144 indicates an intended or proposed resale of 4,000 shares via a cashless exercise on 07/01/2026. Filing a Form 144 notifies regulators of intended resale; it does not by itself confirm completion of sale transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:32 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001770749
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Guardant Health, Inc.
SEC File Number	001-38683
Address of Issuer	3100 HANOVER STREET PALO ALTO CALIFORNIA 94304
Phone	855-698-8887
Name of Person for Whose Account the Securities are To Be Sold	Joyce Meghan V.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	4000	660000.00	132599929	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2026	Employee Stock Option Exercise	GUARDANT HEALTH, INC.			4000	07/01/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/03/2026	10000	1269809.00
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/22/2026	6203	812604.00
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/24/2026	2000	280045.00
Meghan V. Joyce 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/26/2026	2000	300082.00

144: Remarks and Signature

Remarks
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Meghan V. Joyce
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)